𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of mitoxantrone for liver metastases from breast cancer

✍ Scribed by S. M. O'Reilly; R. E. Coleman; R. D. Rubens


Publisher
Springer
Year
1989
Tongue
English
Weight
197 KB
Volume
25
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Liver resection for metastases from brea
✍ Armin Thelen; Christoph Benckert; Sven Jonas; Enrique Lopez-HΓ€nninen; Jalid Seho πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 101 KB
Phase II studies of mitoxantrone in pati
✍ Geoffrey Falkson; Barend Johannes Coetzer πŸ“‚ Article πŸ“… 1985 πŸ› Springer US 🌐 English βš– 147 KB

Forty-nine patients with histologically conlirmed primary liver cancer have been entered on phase II trials of mitoxantrone (NovantroneC"~; dihydroxyanthracenedione), at a dose of 14 mg/m 2 every 3 weeks. Among the patients evaluable for toxicity, leukopenia and thrombocytopenia were the most import

The regional treatment of liver metastas
✍ Dr. Schlomo Schneebaum; Michael J. Walker; Donn Young; William B. Farrar; John P πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 609 KB

To determine the effect of aggressive regional therapy for liver metastasis from breast cancer, we retrospectively reviewed data on 74 patients identified with liver metastases. Forty had only liver metastases. In this group of 40 patients, 18 were treated with regional therapy only, i.e., surgical